L679-0633 Screening compound: N-(3-chloro-4-fluorophenyl)-4-{[3-(3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

L679-0633 Screening compound: N-(3-chloro-4-fluorophenyl)-4-{[3-(3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide
L679-0633 Screening compound: N-(3-chloro-4-fluorophenyl)-4-{[3-(3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L679-0633
N-(3-chloro-4-fluorophenyl)-4-{[3-(3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L679-0633

Molecular Formula

C24H21ClF2N6O (C24 H21 ClF2 N6 O)

Compound Name

N-(3-chloro-4-fluorophenyl)-4-{[3-(3-fluorophenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

IUPAC name

N-(3-chloro-4-fluorophenyl)-4-{[3-(3-fluorophenyl)-3H-imidazo[45-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

SMILES

O=C(Nc(cc1)cc(Cl)c1F)N1CCN(Cc(n2-c3cc(F)ccc3)nc3c2nccc3)CC1

InChI

InChI=1S/C24H21ClF2N6O/c25-19-14-17(6-7-20(19)27)29-24(34)32-11-9-31(10-12-32)15-22-30-21-5-2-8-28-23(21)33(22)18-4-1-3-16(26)13-18/h1-8,13-14H,9-12,15H2,(H,29,34)

InChI Key

NLXUVBHFSKDYDQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27469288

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.92

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.801

Distribution Coefficient, logD

3.799

Water Solubility, LogSw

-4.26

Polar Surface Area

50.803

Acid Dissociation Constant (pKa)

10.35

Base Dissociation Constant (pKb)

4.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

L679-0633 in Drug Discovery

Included in Screening Libraries

Chelators targeting matrix metalloproteinases library (8930 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Proteases
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with L679-0633 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L679-0633?
Check Price and Availability of L679-0633, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L679-0633 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L679-0633
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L679-0633
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L679-0633 available by request